|Mean platelet volume as an indicator of disease severity in patients with acute pancreatitis|
Y Beyazit, A Sayilir, S Torun, B Suvak, Y Yesil, T Purnak, E Oztas, M Kurt, ...
Clinics and research in hepatology and gastroenterology 36 (2), 162-168, 2012
|Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases|
C Efe, S Wahlin, E Ozaslan, AH Berlot, T Purnak, L Muratori, C Quarneti, ...
European journal of gastroenterology & hepatology 24 (5), 531-534, 2012
|Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of hepatitis B virus–related cirrhosis|
S Köklü, Y Tuna, MT Gülşen, M Demir, AŞ Köksal, MC Koçkar, C Aygün, ...
Clinical Gastroenterology and Hepatology 11 (1), 88-94, 2013
|Liver disease and malnutrition|
T Purnak, Y Yilmaz
Best practice & research Clinical gastroenterology 27 (4), 619-629, 2013
|Efficacy and safety of mycophenolate mofetil and tacrolimus as second-line therapy for patients with autoimmune hepatitis|
C Efe, H Hagström, H Ytting, RA Bhanji, NF Müller, Q Wang, T Purnak, ...
Clinical Gastroenterology and Hepatology 15 (12), 1950-1956. e1, 2017
|Mean platelet volume is increased in chronic hepatitis C patients with advanced fibrosis|
T Purnak, S Olmez, S Torun, C Efe, A Sayilir, E Ozaslan, I Tenlik, ...
Clinics and research in hepatology and gastroenterology 37 (1), 41-46, 2013
|Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis|
C Efe, T Kav, C Aydin, M Cengiz, NN Imga, T Purnak, DS Smyk, ...
Digestive diseases and sciences 59 (12), 3035-3042, 2014
|Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis|
E Ozaslan, C Efe, A Heurgué–Berlot, T Kav, C Masi, T Purnak, L Muratori, ...
Clinical Gastroenterology and Hepatology 12 (5), 863-869, 2014
|Association between the presence of brown adipose tissue and non‐alcoholic fatty liver disease in adult humans|
Y Yilmaz, T Ones, T Purnak, S Ozguven, R Kurt, O Atug, HT Turoglu, ...
Alimentary pharmacology & therapeutics 34 (3), 318-323, 2011
|Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases|
C Efe, T Purnak, E Ozaslan, Z Ozbalkan, Y Karaaslan, E Altiparmak, ...
Scandinavian journal of gastroenterology 46 (6), 732-737, 2011
|Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome|
C Efe, E Ozaslan, T Kav, T Purnak, A Shorbagi, O Ozkayar, AH Berlot, ...
Autoimmunity reviews 11 (5), 330-334, 2012
|The development of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome during the course of connective tissue diseases: report of three cases and review of the …|
C Efe, E Ozaslan, N Nasiroglu, H Tunca, T Purnak, E Altiparmak
Digestive diseases and sciences 55 (8), 2417-2421, 2010
|Inflammation and chemerin in colorectal cancer|
S Erdogan, FM Yilmaz, O Yazici, A Yozgat, S Sezer, N Ozdemir, S Uysal, ...
Tumor Biology 37 (5), 6337-6342, 2016
|Can red cell distribution width help to discriminate benign from malignant biliary obstruction? A retrospective single center analysis.|
Y Beyazit, M Kekilli, M Ibis, M Kurt, A Sayilir, IK Onal, T Purnak, E Oztas, ...
Hepato-gastroenterology 59 (117), 1469-1473, 2012
|Drug‐induced autoimmune hepatitis caused by anti–tumor necrosis factor α agents|
C Efe, T Purnak, E Ozaslan, S Wahlin
Hepatology 52 (6), 2246-2247, 2010
|Serum adenosine deaminase activity as a predictor of disease severity in ulcerative colitis|
Y Beyazit, S Koklu, A Tas, T Purnak, A Sayilir, M Kurt, T Turhan, T Celik, ...
Journal of Crohn's and Colitis 6 (1), 102-107, 2012
|Mean platelet volume could be a promising biomarker to monitor dietary compliance in celiac disease|
T Purnak, C Efe, O Yuksel, Y Beyazit, E Ozaslan, E Altiparmak
Upsala journal of medical sciences 116 (3), 208-211, 2011
|Differences in nephrotoxicity risk and renal effects among anti‐viral therapies against hepatitis B|
S Koklu, MT Gulsen, Y Tuna, H Koklu, O Yuksel, M Demir, R Guner, ...
Alimentary pharmacology & therapeutics 41 (3), 310-319, 2015
|Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study|
C Efe, E Ozaslan, S Wahlin, T Purnak, L Muratori, C Quarneti, O Yüksel, ...
Liver International 33 (2), 190-196, 2013
|The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease|
T Purnak, Y Beyazit, E Ozaslan, C Efe, M Hayretci
Wiener Klinische Wochenschrift 124 (15), 526-531, 2012